The photos are not the data. Follistatin before and after posts cluster around two extremes — dramatic eight-week transformations on social media, and quiet trial-grade numbers that look much smaller in print.
Both can be true. Only one helps you plan.
Key takeaways
- Realistic human results land near 3–8% lean mass gain over a 4–8 week cycle — roughly 3–6 kg for a 70 kg lifter, not the 15–20 kg seen on forum posts.
- Recovery, pumps, and training capacity improve before scale weight or visible size.
- The Minicircle plasmid trial reported about 2 lb of lean mass and 0.87% fat reduction at 3 months in 43 healthy adults.
- The sIBM gene therapy trial improved the 6-minute walk by 56 m/year vs −25.8 m/year in untreated controls (p = 0.01).
- Most online "before and after" photos pair a peptide cycle with a calorie surplus, better lighting, and fresh training intensity — not just follistatin.
- Independent testing found that about 8 of 17 vendor follistatin products contained no follistatin at all; many transformations are not what they appear to be.
Follistatin before and after — a realistic timeline
Start with the week-by-week. This is what consistent reports look like when training, nutrition, and sleep are also being run.
| Phase | What you actually notice | What does not change yet | Source signal |
|---|---|---|---|
| Week 1–2 (loading) | Slightly fuller pumps, marginally faster recovery, scale up 2–3 lb (mostly water and glycogen) | Visible muscle size, body fat, lift numbers | Plasmid users see follistatin rise ~160% by week 2 |
| Week 3–4 | Strength climbs 5–15 lb on main lifts, less between-session soreness, mild appetite rise | DEXA-level body composition shifts | Peak myostatin suppression begins |
| Week 4–8 | 1–3 lb lean mass on DEXA, mild fat loss if eating well, visible fullness in arms/shoulders | "Different person" transformation | Trial pattern: 3–5 lb lean / cycle |
| Week 8–12 | Plateau in most peptide cycles; gene-therapy users still trending up | New ceiling without dose change | Minicircle 3-month: ~2 lb lean, −0.87% fat |
| Month 3–6 (gene therapy) | Reported epigenetic age changes, sustained lean-mass | Indefinite effect — clinics quote ~1 year | Minicircle reports ~7 yr epigenetic age drop |
| After stopping | Myostatin returns to baseline within 10–14 days | Trained gains can be preserved if training/protein continue | Rebound but not collapse |
That table is the honest pattern. Everything below explains why each row looks the way it does and where the social-media version diverges.
For the full background, read the follistatin overview and the follistatin gene therapy article — gene therapy results follow a different curve from peptide cycles.
What changes first — recovery, pumps, and capacity
Sequence matters. The earliest signal is almost never visible to a camera.
Across both peptide and gene-therapy reports, the consistent early changes are:
- Better between-session recovery — less DOMS, less drag in the second hard workout of the week.
- Stronger and longer-lasting pumps during training.
- A subtle "fullness" in arms, shoulders, and quads.
- Higher appetite, sometimes uncomfortably so.
- Strength climbs that outrun visible size by 2–4 weeks.
Why does that matter for before-and-after expectations? Because a four-week photo will almost never show the things that are actually happening. The real changes are how training feels, not how the chest looks in a mirror.
What does not change in the first month
Hard list. Cameras like fat loss, definition, and shoulder roundness. Those are usually later.
In the first 28 days a peptide user typically does not see:
- Major fat loss (this is mostly training and diet, not the peptide).
- Dramatic vascularity changes (those need a leaner starting point).
- A new shape in the mirror under standard lighting.
- Lift numbers jumping 50+ lb.
- Any change at all if dosing is missed, the product is poor quality, or training is sporadic.
Honest read: anyone showing a four-week shirtless transformation is usually combining better lighting, posing practice, and a calorie surplus — not just follistatin.
Realistic lean mass numbers from human data
Stack the data side by side. The serious sources cluster around small absolute numbers, much smaller than animal models.
| Source | Population | Result | Notes |
|---|---|---|---|
| Minicircle plasmid trial | 43 healthy adults | ~2 lb (0.9 kg) lean mass, −0.87% fat at 3 months | Single-arm, unblinded, company-run |
| Hypogonadal-male study cited by Real Peptides | Hypogonadal men | 8.2% lean mass over 12 weeks vs 2.1% placebo | Comparator group included |
| AAV1-FS344 sIBM trial (Mendell 2017) | 6 men with sIBM | +56 m/year on 6-min walk vs −25.8 m/year control | Function, not pure mass |
| Engineered mouse models | Mice | 28–69% mass increase | Not a human expectation |
| Macaque AAV studies | Primates | ~15% circumference increase over ~60 weeks | Closer to a ceiling than a typical case |
| Real-world peptide forums | Self-reported | 4–12 lb gains in a 4–6 week cycle | Often paired with surplus and training change |
Translation. The Minicircle data are the cleanest human peptide-grade signal available, and the headline number is roughly 2 lb of lean mass per cycle, not 20.
What hand grip and strength actually do
Strength outruns size. The most consistent before-and-after marker in research and self-report is grip and lift strength rather than waist or chest size.
- The classic 7-day epicatechin/follistatin study (different compound, related pathway) showed hand-grip strength up about 7% in a week.
- Real Peptides reports a case-series serum myostatin drop from 4.2 ng/mL at baseline to 1.1 ng/mL by week four, paired with squat up 18 kg and bench up 12 kg.
- Peptides.wiki documents typical 1-rep max gains of 10–30 lb on bench, squat, or deadlift over 4–6 weeks during a cycle.
- The sIBM trial used a 6-minute walk improvement (+56 m/year) as the practical marker, not a hypertrophy photo.
For lifters tracking before and after honestly, the right log is lift numbers, grip strength on the same dynamometer, and circumference measurements — not phone-camera mirror shots.
Why most online before and after photos are exaggerated
This is where the hype lives. There are four reasons online transformations look bigger than they are.
- Diet and training change at the same time. Going from a maintenance plan to a 500-calorie surplus and a hard six-day split alone explains most "follistatin transformations."
- Lighting, posing, and pump timing. Front-double-bicep with a back pump under overhead lighting is a different person than slumped-shoulders fluorescent kitchen lighting.
- Vial purity. About 8 of 17 vendor follistatin products in WADA forensic testing contained no follistatin at all, and the 9 that did showed His-tags or clumping. Many "users" are running other peptides or contaminated material.
- Selection bias. Transformations that look identical to a normal calorie surplus do not get posted; the most flattering before-and-afters do.
A reasonable before/after target is to underweight social-media examples and overweight the small trial-grade numbers when planning. That is the inverse of how most readers do it.
Realistic before/after by user profile
Results depend on starting point. Here is the rough mapping.
| Profile | Realistic 4–6 week change | Notes |
|---|---|---|
| Untrained beginner | 8–15 lb scale gain, lift PRs every session | Most of this is normal beginner adaptation; peptide is small contributor |
| Returning lifter (1–2 yr break) | 5–10 lb gain, big strength bump | Muscle memory effect is the bigger driver |
| Intermediate (2–5 yr training) | 3–8 lb lean mass, 10–25 lb on main lifts | The clearest "peptide signal" range |
| Advanced (5+ yr training) | 2–5 lb lean mass, modest PRs | Closer to natural ceiling; gains are smaller but still meaningful |
| Older adult / frailty risk | Modest lean mass, large functional gain | Closer to the sIBM-trial pattern; function beats mass |
| Cutting in a deficit | Better lean preservation, small strength edge | Not a fat-loss tool by itself |
Anyone planning a cycle around aesthetic before-and-afters should know that the intermediate/advanced ranges are where the peptide-attributable signal is most visible — and even there, it is single-digit pounds, not double-digit.
Gene therapy before and after — a different curve
This is a separate timeline. The Minicircle plasmid pattern is slower to peak and slower to fade than peptide cycles.
- Week 2: serum follistatin up roughly 160% in Bryan Johnson's disclosure.
- Month 1–2: training-recovery and pump signals appear.
- Month 3: trial readout — ~2 lb lean, −0.87% fat, ~7 yr epigenetic age reduction (Minicircle).
- Month 6: Bryan Johnson reported 7% muscle mass increase from a 99th-percentile baseline.
- Month 9–12: serum follistatin drifts back toward baseline; most clinics reassess.
It is a more expensive, more committed protocol with longer-lasting effects, and it is also less proven outside a single-arm company trial. The follistatin gene therapy article lays out the full data and limitations.
What does not show up in a transformation post
Less marketed but real. The honest report includes:
- Injection-site soreness for a day or two after each shot.
- New joint or tendon niggles around week 3–6, especially in shoulders or elbows.
- Mild headaches or fatigue in the first week.
- Temporary FSH drop of 15–30%, sometimes more at high systemic exposure.
- Mild ALT rise in roughly 17% of subjects on longer FS-315 protocols.
- A real possibility that the vial is mislabeled or contaminated.
Those points are why the follistatin side effects article is required reading before any cycle, and why short cycles outperform long ones for safety.
How to track your own before and after honestly
Practical method. Skip the kitchen mirror and use these instead.
- Photos: same lighting, same time of day, same outfit, same body fat estimate week to week.
- Lift log: top set on three main lifts each week, same form, same rep target.
- Circumference: arm at peak, chest at nipple line, quad mid-belly, waist at navel.
- Grip strength: same dynamometer, same hand position, three trials averaged.
- Bloods: FSH/LH, CBC, CMP at baseline, week 4, and a month after stopping.
- Bodyweight: same scale, same time of day, weekly average rather than daily reading.
If you record those six items, you will know whether a cycle did anything beyond placebo. Without them, you are guessing — and Instagram already shows you what guessing looks like.
Sources and notes
This article was built from DuckDuckGo and Bing SERP review, full-page competitor checks, and the underlying clinical and observational sources.
- Minicircle plasmid follistatin trial preprint
- Mendell 2017 — Follistatin gene therapy for sporadic inclusion body myositis
- Bryan Johnson — six-month follistatin gene therapy update
- Peptides.wiki — Follistatin 344 before and after
- Real Peptides — Follistatin-344 before and after
- The Peptide Catalog — Follistatin results week-by-week timeline
- MyPeptideMatch — Follistatin 315 results
- Tiger Fitness — Follistatin 344 reality check
- Stacktrax — WADA forensic study on vendor follistatin purity
Frequently Asked Questions
How long until I see results from follistatin?
Recovery, pumps, and training capacity usually improve in week 1–2. Visible body-composition changes typically appear from week 4 onward. Most peptide cycles plateau by week 8.
How much muscle can I really gain in a follistatin cycle?
Realistic human data point to 3–8% lean mass over 4–8 weeks — roughly 3–6 kg for a 70 kg lifter. Forum-grade claims of 15–20 kg gains almost always reflect a calorie surplus, beginner adaptation, or different compounds.
Are follistatin before and after photos online real?
Some are; many are not. Photo angle, lighting, pump timing, diet changes, and vial purity drive most of the difference. Independent testing found about 8 of 17 vendor follistatin products contained no follistatin at all.
What changes first when starting follistatin?
Better training recovery, longer pumps, and small early strength gains usually appear before visible size or fat loss. The Minicircle plasmid trial showed serum follistatin rising sharply by week 2, with body-composition shifts becoming clear closer to month 3.
Do gains stay after stopping follistatin?
Some do. Myostatin returns to baseline within 10–14 days, but the lean mass and strength built during the cycle can be preserved if training and protein intake continue. Cycle-end "collapse" stories are usually overstated.
Is the Minicircle gene therapy before and after better than a peptide cycle?
It is slower-onset, longer-lasting, and more expensive. The Minicircle 3-month readout was about 2 lb lean mass, −0.87% fat, and a reported ~7-year epigenetic age drop — clinically interesting numbers, not a dramatic visual transformation.
This article is for educational purposes only and is not medical advice. Follistatin peptides and follistatin gene therapies lack FDA clearance for human use, are prohibited in regulated sport, and have important unknown long-term risks. Talk with a qualified clinician before any cycle, especially if you take medication, plan a pregnancy, or have a cancer, fertility, hormonal, tendon, or eye history.
